Zinc News and Research

RSS

Zinc is an essential mineral that is naturally present in some foods, added to others, and available as a dietary supplement. Zinc is also found in many cold lozenges and some over-the-counter drugs sold as cold remedies.

Zinc appears to help boys learn

Seventh graders given 20 mg zinc, five days per week, for 10 to 12 weeks showed improvement in mental performance, responding more quickly and accurately on memory tasks and with more sustained attention, than classmates who received no additional zinc.

4 Apr 2005

Gene identified that confers susceptibility to age-related macular degeneration

By combining the tools of high-throughput biology and statistical genetics, scientists at Rockefeller University, Yale University School of Public Health and the National Eye Institute have identified a gene that confers susceptibility to age-related macular degeneration (AMD), the most common cause of vision loss in the United Sates for those over 60.

14 Mar 2005

Increases in macronutrient consumption during pregnancy can lead to increased birthweight

Giving pregnant women in the developing world a daily supplement containing 10 vitamins and five minerals could help increase the birthweight of their babies, concludes a study published online by The Lancet.

3 Mar 2005

Scientists identify immune-system mutation

A team of Fox Chase Cancer Center scientists led by immunologist Dietmar J. Kappes, Ph.D., has identified the genetic mutation that keeps a mouse strain from developing white blood cells, or lymphocytes, called helper T cells. The report by Kappes and his colleagues appears in the Feb. 24 issue of Nature.

27 Feb 2005

Zinc treatment may help prevent esophageal and oral cancers

Cancer researchers at Jefferson Medical College and the Kimmel Cancer Center at Thomas Jefferson University in Philadelphia have found that zinc treatment may help prevent esophageal and oral cancers in those individuals at high risk.

9 Jan 2005

Low-dose antioxidant supplementation may reduce the risk of cancer among men, but not in women

According to the article, antioxidants including beta carotene, ascorbic acid, vitamin E, selenium, and zinc may prevent some of the harmful effects caused by free radicals – reactive molecules produced by metabolism in the body.

23 Nov 2004

Interaction of nervous system proteins help researchers better understand age-related memory and hearing loss

In a finding that may one day help researchers better understand age-related memory and hearing loss, scientists have shown that two key nervous system proteins interact in a manner that helps regulate the transmission of signals in the nervous system.

29 Oct 2004

Researchers stimulate the body to repair tissue damaged by peripheral arterial obstructive disease

Duke University Medical Center researchers have shown that they can stimulate the body to produce its own naturally occurring growth factors to promote blood vessel growth into tissue damaged by peripheral arterial obstructive disease (PAOD).

13 Oct 2004

Nanotechnology company pSivida granted European patent

Nanotechnology company pSivida has announced that its UK operating subsidiary pSiMedica Limited has been granted a further patent for BioSiliconTM.

13 Oct 2004

Balanced diet reduces the risk of a baby with spina bifida

According to Dutch researcher Pascal Groenen, a balanced diet reduces the risk of a baby with spina bifida. He investigated how different nutritional components affected the risk of developing this condition.

11 Oct 2004

Large percentage of child deaths related to malaria are attributable to undernutrition and deficiencies

A large percentage of child deaths related to malaria are attributable to undernutrition and deficiencies of vitamin A, zinc, iron and folate, according to a new report by researchers with the Johns Hopkins Bloomberg School of Public Health.

20 Aug 2004

Zinc plays a crucial role in blindness

Dartmouth Medical School researchers in their quest to find cures for inherited diseases have found that zinc plays a crucial role in blindness in over one million people worldwide.

18 Aug 2004

The U.S. FDA approves 2 drugs for treating radiation contamination

The U.S. Food and Drug Administration has approved two drugs, pentetate calcium trisodium injection (Ca-DTPA) and pentetate zinc trisodium injection (Zn-DTPA) for treating certain kinds of radiation contamination. The FDA is approving these two drugs as part of its ongoing effort to provide the American public the best available protection against nuclear accidents and terrorist threats.

11 Aug 2004

Antioxidant pills do nothing to prevent cardiovascular disease

Research published in the current issue of the Journal of the American Heart Association, shows that antioxidant pills have no clear benefit in the prevention of cardiovascular disease.

2 Aug 2004

In-depth study into how heavy metals exposure at the Tar Creek Superfund Site in Oklahoma may affect the health of children

Unlike many studies that investigate the health effects of a single chemical, the new center will study how exposure to mixtures of metals affects health—reflecting more accurately the nature of toxic waste dumps where multiple chemicals may be present.

9 Jul 2004

Class of molecules that could lead to treatments for a wide range of diseases, including cancer, arthritis, and heart disease

By making use of model compounds in drug design, chemists at the University of California, San Diego identified a class of molecules that could lead to treatments for a wide range of diseases, including cancer, arthritis, and heart disease.

21 Jun 2004

Fruit consumption may protect against age-related maculopathy (ARM)

Eating fruit may help protect against the development of age-related maculopathy (ARM), an eye disease that can cause blindness, according to an article in the June issue of the Archives of Ophthalmology, one of the JAMA/Archives journals.

15 Jun 2004

Zinc may help to accelerate recovery from pneumonia

The addition of zinc to standard antimicrobial treatment may accelerate recovery from pneumonia, say researchers in this week's issue of The Lancet.

20 May 2004

Scientists closer to a potential vaccine or treatment for botulism

By deciphering the near atomic-level structure of the catalytic domain of botulinum toxin type E — one of seven neurotoxins that cause botulism, a disease that paralyzes victims by blocking nerve cells’ ability to communicate — scientists at the U.S. Department of Energy’s Brookhaven National Laboratory are one step closer to a potential vaccine or treatment.

10 May 2004

First canine insulin drug

FDA has approved a porcine insulin zinc suspension product as the first drug for treating diabetic dogs. Prior to the development of this product, the only treatment veterinarians could use on diabetic dogs was human insulin, which is less compatible with a dog’s metabolic system.

4 May 2004